CCC Project - Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- Registration Number
- NCT02309398
- Lead Sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases
- Brief Summary
The purpose of this study is to develop and implement quality improvement programs for the treatment of atrial fibrillation (AF) in China based on the successful experience of the AHA-Get with the Guidelines program. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of atrial fibrillation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 67028
- Hospitalized patients with discharge diagnosis as atrial fibrillation in 150 tertiary and 100 secondary hospitals.
None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The overall composite of six performance measures for AF care Duration of hospital stay, an expected average of 1 week Performance measures for AF care including:
1. Proportion of patients received assessment of thromboembolic risk factors
2. Proportion of patients discharged on warfarin or other anticoagulant drug
3. Proportion of patients discharged on warfarin who have PT/INR follow-up planned prior to hospital discharge
4. Proportion of patients with left ventricular systolic dysfunction prescribed an ACEI or ARB at hospital discharge
5. Proportion of patients with left ventricular systolic dysfunction prescribed a beta blocker at hospital discharge
6. Proportion of patients with either coronary artery disease, cerebrovascular accident/transient ischemic attack, peripheral vascular disease or diabetes who were prescribed a statin at hospital discharge
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Beijing An Zhen Hospital
🇨🇳Beijing, China